TERRA ROCKENFIELD: Open Payments
NPI 1023349982 · MORGAN, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$659 in 39 payments from 12 companies in 2025. Trend: 2023 $756 · 2024 $909 · 2025 $659
Food & beverage: $659
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $219 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $141 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $68 |
| Indivior Inc. | 2 | $49 |
| PFIZER INC. | 2 | $44 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Inspire Medical Systems, Inc. | 1 | $25 |
| Amgen Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Exact Sciences Corporation | 1 | $14 |
Products named: CAPLYTA, VRAYLAR, JARDIANCE, SUBLOCADE, UBRELVY, NURTEC ODT, Auvelity, QULIPTA.
Industry payments across UT — which companies pay providers there.
